ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Cucurbit[8]Uril Achieved Single-Molecule Chiral Transfer to Supramolecular Circularly Polarized Luminescence.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Herein, cascaded supramolecular assembly was constructed from phenylalanine-modified biphenyl-pyridine derivatives (L/D-FPy), cucurbit[8]uril (CB[8]), and amphipathic sulfonatocalix[4]arene (SC4AD), which not only exhibits cascaded energy transfer and chiral transfer but also achieves amplified circularly polarized luminescence (CPL). The experimental results demonstrate that L/D-FPy and SC4AD directly assemble through electrostatic interactions to form particles, where the luminescence intensity and quantum yield (QY) were significantly enhanced by 140 and 8 times, respectively. The positively charged L/D-FPy and CB[8] combine to form a 1:1 stoichiometric supramolecular assembly. Compared with the L/D-FPy@SC4AD assembly, the system with added SC4AD in the presence of CB[8] exhibited a 2.5‑fold enhancement in luminescence intensity and QY, and also amplification of chirality. Taking advantage of the energy transfer and chiral transfer, L/D-FPy⊂CB[8]@SC4AD co-assembly with the achiral dyes benzothiadiazole (DBT) and Nile red (NR), and the polymer polyvinyl alcohol (PVA), markedly increased the CPL. The luminescence asymmetry factor values for L/D-FPy⊂CB[8]@SC4AD:NR were estimated to be-4.05 × 10
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.